Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02604524 · ClinicalTrials.gov registry record · NA

Reducing Risks and Improving Glucose Control During Extended Exercise in Youth With T1DM: The AP Ski Camp

A NA study of Type 1 Diabetes Mellitus, sponsored by Daniel Chernavvsky, MD, CRC.

Completed
Registry status
NA
Development phase
32
Enrollment target
2
Study locations

NCT02604524 is a NA study of Type 1 Diabetes Mellitus that has completed, run by Daniel Chernavvsky, MD, CRC. The registered enrollment target is 32 participants, below the 140-participant average among 105 other Type 1 Diabetes Mellitus trials with a reported enrollment target (77% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02604524, a NA study of Type 1 Diabetes Mellitus, has completed, sponsored by Daniel Chernavvsky, MD, CRC.

COMPLETED
Registry status
NA
Development phase
32 participants
Enrollment target
2
Study locations

Study Summary

The biggest challenges for glycemic control during the day time involve meals and exercise variations, which are impacted by age, fitness level, duration, intensity and history of exercise. Meal variability has the benefit that meals are typically announced and quantified. Glucose control around exercise, on the other hand, is more complicated if the patient doesn't announce a change in activity level.

Conditions Studied

Interventions

  • DEVICE Closed-Loop Control
  • OTHER Sensor Augmented Pump Therapy

Study Locations (2)

Colorado

  • University of Colorado, Denver, Barbara Davis Center - Aurora

Virginia

  • University of Virginia - Charlottesville

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2016-01
Est. Completion 2016-04
Phase NA

Sponsor

Daniel Chernavvsky, MD, CRC

1 total trials

What the Registry Record Tells You About NCT02604524

The ClinicalTrials.gov registry entry for NCT02604524 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 140-participant average among 105 other Type 1 Diabetes Mellitus trials with a reported enrollment target (77% lower). The listed sponsor is Daniel Chernavvsky, MD, CRC, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Type 1 Diabetes Mellitus appearing as the primary indexed condition, and to 2 interventions - of which Closed-Loop Control is the first listed.

NCT02604524 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Colorado, Virginia.

Frequently Asked Questions

What is clinical trial NCT02604524 about?

NCT02604524 is a clinical study titled "Reducing Risks and Improving Glucose Control During Extended Exercise in Youth With T1DM: The AP Ski Camp". The biggest challenges for glycemic control during the day time involve meals and exercise variations, which are impacted by age, fitness level, duration, intensity and history of exercise. Meal variability has the benefit that meals are typically announced and quantified. Glucose control around exe...

What is the current status of trial NCT02604524?

This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2016-01. Estimated completion is 2016-04.

What conditions does trial NCT02604524 study?

This clinical trial studies the following conditions: Type 1 Diabetes Mellitus.

What interventions are being tested in trial NCT02604524?

The interventions under investigation include: Closed-Loop Control (DEVICE), Sensor Augmented Pump Therapy (OTHER).

Who is sponsoring clinical trial NCT02604524?

This trial is sponsored by Daniel Chernavvsky, MD, CRC, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02604524 being conducted?

This trial has 2 study locations across Colorado, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Type 1 Diabetes Mellitus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.